Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 100 | uM | 9047.037 | 0.0825 | -0.9826 | 0.5262 | |
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 8 | uM | 12509.143 | 0.9222 | 0.8826 | 1.3392 | |
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 0.032 | uM | 9047.037 | 0.4452 | -0.5704 | 0.5262 | |
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 20 | uM | 9047.037 | 0.3683 | -0.7003 | 0.5262 | |
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 0.064 | uM | 12509.143 | 1.0070 | 1.0104 | 1.3392 | |
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 1.6 | uM | 12509.143 | 1.0174 | 1.0259 | 1.3392 | |
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 0.000256 | uM | 9047.037 | 0.9096 | 0.6705 | 0.5262 | |
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 0.0064 | uM | 9047.037 | 0.9396 | 0.7765 | 0.5262 | |
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 0.16 | uM | 9047.037 | 0.4280 | -0.6013 | 0.5262 | |
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 4 | uM | 9047.037 | 0.4226 | -0.6108 | 0.5262 | |
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 0.0128 | uM | 12509.143 | 1.0576 | 1.0853 | 1.3392 | |
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 9047.132 | 0.8736 | 0.6481 | 0.6985 | ||
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 6.67 | uM | 9047.132 | 0.8373 | 0.5511 | 0.6985 | ||
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 0.32 | uM | 12509.143 | 1.0571 | 1.0846 | 1.3392 | |
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 33.3 | uM | 9047.132 | 0.7816 | 0.4055 | 0.6985 | ||
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 9047.132 | 0.9788 | 0.9394 | 0.6985 | ||
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 167 | uM | 9047.132 | 0.9698 | 0.9141 | 0.6985 | ||
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 0.00128 | uM | 9047.037 | 1.0758 | 1.2981 | 0.5262 | |
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.267 | uM | 9047.132 | 0.9995 | 0.9985 | 0.6985 | ||
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.000427 | uM | 9047.132 | 1.0270 | 1.0778 | 0.6985 | ||
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 0.00213 | uM | 9047.132 | 0.9693 | 0.9128 | 0.6985 | ||
184A1 | NM | Basal | 17-AAG | HSP90 | HSP90 | 0.8 | uM | 9047.037 | 0.4311 | -0.5959 | 0.5262 | |
184A1 | NM | Basal | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 9047.132 | 0.9661 | 0.9036 | 0.6985 | ||
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 200 | uM | 12509.143 | 0.6536 | 0.4559 | 1.3392 | |
184A1 | NM | Basal | 5-DFUR | TYMS | TYMS | 40 | uM | 12509.143 | 0.8213 | 0.7265 | 1.3392 |